Plus therapeutics appoints chief financial officer

Austin, texas, feb. 06, 2020 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv ) (the “company”), today announced that andrew j. sims has been appointed as the company’s chief financial officer, effective february 5, 2020.

pstv Ratings Summary

pstv Quant Ranking